Zurich Cantonal Bank
NVAX icon

Zurich Cantonal Bank’s Novavax NVAX Stock Holding History

Zurich Cantonal Bank’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-113,623
Closed -$764K – 3185
2025
Q4 		$764K Buy
+113,623
New +$857K ﹤0.01% 1514

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zurich Cantonal Bank's NVAX Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Novavax (NVAX) in Q1 2026: 47,980 shares worth $391K. The stake represents ﹤0.01% of the portfolio and ranks #1953 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in NVAX as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in NVAX in Q1 2015 and has held it in 42 quarters since. The position peaked at $4.46M in Q3 2021. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Zurich Cantonal Bank held 47,980 shares of Novavax worth $391K as of Q1 2026.
  • Novavax was a new Zurich Cantonal Bank position in Q1 2026.
  • Novavax made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1953 holding.
  • Zurich Cantonal Bank first reported a position in Novavax in Q1 2015 and has held it in 42 quarters since.
  • Zurich Cantonal Bank's Novavax position peaked at $4.46M in Q3 2021.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.